Amgen Sales 2024 - Search News

Amgen Inc (AMGN) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Expansions

Amgen Inc (AMGN) reports a 19% revenue increase, driven by strong product sales and strategic international expansions, despite facing market challenges.

The Motley Fool on MSN · 1d

Amgen (AMGN) Q4 2024 Earnings Call Transcript

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speakers' prepared remarks. In order to ensure that everyone has a chance to participate,

Business Insider · 1d

AMGN Earnings: Amgen Slips on Soft EPS Guidance

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter of Fiscal Year

Benzinga.com · 16h

Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead

Amgen posted Q4 sales of $9.1 billion, up 11%, surpassing forecasts. EPS beat estimates, and analysts remain optimistic about growth prospects in 2025.

The Motley Fool on MSN · 1d

Merck (MRK) Q4 2024 Earnings Call Transcript

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter Dannenbaum,

Seeking Alpha · 10h

Douglas Emmett, Inc. (DEI) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Conference Call February 5, 2025 2:00 PM ETCompany ParticipantsStuart McElhinney – Vice President

13h

Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

FiercePharma17h

With recent launches and more to come, Amgen's biosimilar business is trending up

After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...

precisionmedicineonline16h

Amgen Reports More Than $2B in Oncology Revenues in Q4

Sales of the firm's bispecific T-cell engager Blincyto increased more than 50 percent from the fourth quarter of 2023 to 2024.

1don MSN

Amgen targets $34.3B-$35.7B in 2025 revenues with strong growth in key therapeutic areas

Q4 2024 Management View Amgen highlighted its robust performance in 2024, achieving 14 products annualizing over $1 billion in sales. CEO Robert Bradway emphasized the company's resilience in ...

23h

Amgen Reports Fourth Quarter And Full Year 2024 Financial Results

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...

StockStory.org on MSN14h

Why Amgen (AMGN) Stock Is Trading Up Today

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 5.3% in the morning session after the company reported strong ...

Amgen Q4 Earnings Preview: Street expects revenue to rise more than 8%

Biopharmaceutical company Amgen (AMGN) is set to announce its fourth quarter earnings results on Tuesday, February 4th, after ...

Morningstar5d

AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

THOUSAND OAKS, Calif., Jan. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2024 financial results on Tuesday, February 4 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results